Azithromycin for Injection Blend from Canada
Lyophilized bulk blend of azithromycin with lyoprotectants for reconstitution into anti-infective IV solutions treating pneumonia. Classified in 3003.90.01.80 for its mixed constituents, therapeutic anti-infective intent, and lack of retail/measured dosing. Used in large-scale hospital supply chains.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Submit DMF and validation data for lyophilization process compliance
• Ensure packaging prevents interpretation as 'put up for retail sale'
• Declare as 'other' anti-infectives only if not matching specific subheadings